Thrombosis
Last updated: Saturday, 05, February, 2011
| Key Information | Appropriate Tests |
|---|---|
See Thrombophilia | |
Arterial | Most instances of arterial thromboembolism are due to abnormalities in the vessel wall and/or blood flow. Evidence does not support routine testing for the factors associated with venous thrombosis. |
Embolic | |
Cardiac/valvular
| |
Aorta/proximal artery
| |
Local thrombosis
| |
Predisposing abnormalities | |
Abnormal vascular surface | |
| See Atherosclerosis: risk assessment. |
| |
Abnormal/turbulent blood flow
| |
Blood abnormalities | |
| APTT, lupus inhibitor; cardiolipin antibodies. |
FBC | |
| FBC |
| Homocysteine; testing for mutations of methyl tetra hydrofolate reductase (MTHFR) gene. |
Venous | |
Predisposing abnormalities | |
Abnormal blood flow | |
Venous stasis
| |
Vein wall injury/disease
| |
Blood abnormalities: | Investigation may be indicated when venous thromboembolism is unexplained or recurrent; occurs in unusual sites; occurs in a young patient, or in a patient with a positive family history. |
Acquired blood abnormalities | |
| APTT, lupus inhibitor, cardiolipin antibodies. |
FBC. | |
| Antithrombin assay. |
| See also Venous stasis, above. |
| |
| |
| |
| Patients with pre-existing protein C deficiency are at particular risk. |
| FBC, HITT's antibody screen and confirmatory testing. |
Inheritedblood abnormalities | |
| Activated protein C resistance test; molecular genetics - individual genetic disorders - Factor V Leiden mutation. |
| Antithrombin assay. |
| Protein C, protein S assays. |
| Protein C, protein S assays. |
| Molecular genetics - individual genetic disorders - Prothrombin mutation. |
| Thrombin time, reptilase time. For further investigation - consult pathologist. |
| |
Superficial thrombophlebitis | |
Malignancy | |
Carcinoma
|
